RU2014130894A - PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS - Google Patents
PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS Download PDFInfo
- Publication number
- RU2014130894A RU2014130894A RU2014130894/04A RU2014130894A RU2014130894A RU 2014130894 A RU2014130894 A RU 2014130894A RU 2014130894/04 A RU2014130894/04 A RU 2014130894/04A RU 2014130894 A RU2014130894 A RU 2014130894A RU 2014130894 A RU2014130894 A RU 2014130894A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- asn
- glu
- gly
- arg
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Пептид формулы Thr-Gly-Glu-Asn-His-Arg-NH, обладающий нейропротекторной и ноотропной активностью.2. Фармацевтическая композиция на основе пептида для профилактики и лечения нейродегенеративных и цереброваскулярных заболеваний, высокоэффективная в низких дозах и используемая в виде капель в нос, состава, г/л:гексапептид Thr-Gly-Glu-Asn-His-Arg-NH2,5нипагин (консервирующее вещество) 1,00хлорид натрия (создает в получаемом раствореосмотическое и онкотическое давление, близкоек таковым показателям плазмы крови)-…………… 10,00карбопол (облегчает проникновение лекарственногосредства через слизистую оболочку) 2,5вода дистиллированная остальное1. The peptide of the formula Thr-Gly-Glu-Asn-His-Arg-NH, with neuroprotective and nootropic activity. Peptide-based pharmaceutical composition for the prevention and treatment of neurodegenerative and cerebrovascular diseases, highly effective in low doses and used as nasal drops, composition, g / l: Thr-Gly-Glu-Asn-His-Arg-NH2,5nipagin hexapeptide (preserving substance) 1.00 sodium chloride (creates osmotic and oncotic pressure in the resulting solution, which is close to those of blood plasma) - …………… 10.00 carbopol (facilitates the penetration of the drug through the mucous membrane) 2.5 water is distilled th rest
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014130894/04A RU2557003C2 (en) | 2014-07-25 | 2014-07-25 | Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014130894/04A RU2557003C2 (en) | 2014-07-25 | 2014-07-25 | Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014130894A true RU2014130894A (en) | 2014-10-20 |
RU2557003C2 RU2557003C2 (en) | 2015-07-20 |
Family
ID=53380316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014130894/04A RU2557003C2 (en) | 2014-07-25 | 2014-07-25 | Peptide having neuroprotective and nootropic activity and pharmaceutical composition based thereon |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2557003C2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2662429C1 (en) * | 2017-08-01 | 2018-07-26 | Общество с ограниченной ответственностью "Нейропепт" | Peptide with neuroprotective activity on model of mftp-induced parkinsonism and a pharmaceutical composition on its basis |
RU2682039C1 (en) * | 2018-05-23 | 2019-03-14 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Peptide, possessing anti-tumor and anti-metastatic activity, and finished dosage form based thereon |
RU2704621C1 (en) * | 2018-08-01 | 2019-10-30 | Евгений Владимирович Зиновьев | Pharmaceutical composition for treating burn skin lesions |
RU2743293C1 (en) * | 2020-07-06 | 2021-02-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Use of Gly-His-Lys-Val-Glu-Pro peptide to improve learning abilty and memory. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000053626A1 (en) * | 1999-03-11 | 2000-09-14 | Institut Bioorganicheskoi Khimii Imeni Akademikov M.M.Shemyakina I Ju.A.Ovchinnikova Rossiiskoi A Kademii Nauk | Peptide having an antitumoral, protection and normalisation activity and pharmaceutical composition |
-
2014
- 2014-07-25 RU RU2014130894/04A patent/RU2557003C2/en active
Also Published As
Publication number | Publication date |
---|---|
RU2557003C2 (en) | 2015-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190777T1 (en) | Rapid-acting insulin compositions | |
WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
RU2014130894A (en) | PEPTID POSSESSING NEUROPROTECTOR AND NOTROPIC ACTIVITY, AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
ECSP16084317A (en) | PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE | |
WO2014165607A3 (en) | Aromatic-cationic peptide formulations, compositions and methods of use | |
WO2015183995A3 (en) | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof | |
EA201500061A1 (en) | PHARMACEUTICAL COMPOSITION FOR THERAPY FOR PULMONARY FORMS OF HIGH-DISTANCE DISEASE, CAUSED BY OXYGEN FASTENGEN AND REDUCED ATMOSPHERIC PRESSURE | |
CO2020008308A2 (en) | Modified lipidated relaxin b-chain peptides and their therapeutic use | |
CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
AR114324A1 (en) | MODIFIED LIPIDED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE | |
BR112019002719A2 (en) | acetyl leucine, or a pharmaceutically acceptable salt thereof, for use in methods related to lysosomal deposition diseases | |
MX2019008489A (en) | Treatment comprising oral or gastric administration of edaravone. | |
AU2015242791A1 (en) | Drug Delivery Enhancer Comprising Substance For Activating Lysophospholipid Receptors | |
AR114323A1 (en) | MODIFIED RELAXIN B-CHAIN PEPTIDES AND THEIR THERAPEUTIC USE | |
WO2014164285A3 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
BR112015021265A2 (en) | enhancement methods of use for recombinant human secretoglobins | |
BR112017001695A2 (en) | combination therapy | |
PE20210123A1 (en) | METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE OF THE SAME | |
MX2018005363A (en) | Pharmaceutical composition intended to be administred to nasal mucosa. | |
RU2014117294A (en) | 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE | |
AR097613A1 (en) | DOSAGE OF GIP / GLP-1 CO-ANTAGONIST PEPTIDES FOR HUMAN ADMINISTRATION | |
EA201501130A1 (en) | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | |
PH12016501500B1 (en) | Topical formulations of heparin | |
RU2013105211A (en) | APPLICATION OF TERAPEPTIDE Arg-Pro-Gly-Pro AS A MEANS FOR PREVENTION AND TREATMENT OF HYPERCHOLESTERINEMIA, METHOD FOR PREVENTION AND TREATMENT OF HYPERCHOLESTEREMIA, PHARMACEUTICAL CHEMISTROSIS | |
CL2018003269A1 (en) | Carboxylic acids for application in early childhood. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
QB4A | Licence on use of patent |
Free format text: LICENCE Effective date: 20170515 |